Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Xtant Medical Holdings (XTNT) over the last 13 years, with Q3 2025 value amounting to $17000.0.

  • Xtant Medical Holdings' Gains from Investment Securities changed 0.0% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $67000.0, marking a year-over-year decrease of 9942.72%. This contributed to the annual value of $65000.0 for FY2024, which is 9944.42% down from last year.
  • Latest data reveals that Xtant Medical Holdings reported Gains from Investment Securities of $17000.0 as of Q3 2025, which was down 0.0% from $17000.0 recorded in Q2 2025.
  • Over the past 5 years, Xtant Medical Holdings' Gains from Investment Securities peaked at $11.6 million during Q4 2023, and registered a low of $8000.0 during Q3 2021.
  • Its 5-year average for Gains from Investment Securities is $855659.7, with a median of $16000.0 in 2023.
  • In the last 5 years, Xtant Medical Holdings' Gains from Investment Securities soared by 7755333.33% in 2023 and then tumbled by 9986.26% in 2024.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Gains from Investment Securities stood at $8000.0 in 2021, then surged by 87.5% to $15000.0 in 2022, then skyrocketed by 77553.33% to $11.6 million in 2023, then crashed by 99.86% to $16000.0 in 2024, then rose by 6.25% to $17000.0 in 2025.
  • Its Gains from Investment Securities stands at $17000.0 for Q3 2025, versus $17000.0 for Q2 2025 and $17000.0 for Q1 2025.